Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

NCT00101374 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Leflunomide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)